Statins prevent oxidized low-density lipoprotein- and lysophosphatidylcholine-induced proliferation of human endothelial cells

Vascular Pharmacology

Volumn 41, Issue 2, 2004, Pages 67-73

  Schaefer, Christian Alexander ^a   Wolfram Kuhlmann, Christoph Rüdiger ^a   Gast, Christine ^a   Weiterer, Sebastian ^a   Li, Fang ^a   Most, Astrid Kerstin ^a   Neumann, Thomas ^a   Backenköhler, Ulrich ^a   Tillmanns, Harald ^a   Waldecker, Bernd ^a   Wiecha, Johannes ^a   Erdogan, Ali ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Endothelial cells; Lysophosphatidylcholine; oxLDL; Proliferation; Statin

Indexed keywords

CERIVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; LYSOPHOSPHATIDYLCHOLINE; MEVALONIC ACID; SIMVASTATIN; THYMIDINE; TRITIUM;

ARTICLE; CELL COUNT; CELL GROWTH; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; ENDOTHELIUM CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; INHIBITION KINETICS; LIPID OXIDATION; PRIORITY JOURNAL; UMBILICAL VEIN;

CELL DIVISION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; GROWTH INHIBITORS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIPOPROTEINS, LDL; LYSOPHOSPHATIDYLCHOLINES;

EID: 2942545972     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2004.05.002     Document Type: Article

References (22)

1. Auge N., Escargueil-Blanc I., Lajoie-Mazenc I., Suc I., Andrieu-Abadie N., Pieraggi M.T., Chatelut M., Thiers J.C., Jaffrezou J.P., Laurent G., Levade T., Negre-Salvayre A., Salvayre R. Potential role for ceramide in mitogen-activated protein kinase activation and proliferation of vascular smooth muscle cells induced by oxidized low density lipoprotein. J. Biol. Chem. 273:1998;12893-12900
2. Axel D.I., Riessen R., Runge H., Viebahn R., Karsch K.R. Effects of cerivastatin on human arterial smooth muscle cell proliferation and migration in transfilter cocultures. J. Cardiovasc. Pharmacol. 35:2000;619-629
3. Breuer H.W. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin. Curr. Med. Res. Opin. 17:2001;60-73
4. Caplan B.A., Schwartz C.J. Increased endothelial cell turnover in areas of in vivo Evans blue uptake in the pig aorta. Atherosclerosis. 17:1973;401-417
5. Crisby M., Kallin B., Thyberg J., Zhivotovsky B., Orrenius S., Kostulas V., Nilsson J. Cell death in human atherosclerotic plaques involves both oncosis and apoptosis. Atherosclerosis. 130:1997;17-27
6. Dobrucki L.W., Kalinowski L., Dobrucki I.T., Malinski T. Statin-stimulated nitric oxide release from endothelium. Med. Sci. Monit. 7:2001;622-627
7. Galle J., Mulsch A., Busse R., Bassenge E. Effects of native and oxidized low density lipoproteins on formation and inactivation of EDRF. Arterioscler. Thromb. Vasc. Biol. 11:1991;198-203
8. Heinloth A., Heermeier K., Raff U., Wanner C., Galle J. Stimulation of NADPH oxidase by oxidized low-density lipoprotein induces proliferation of human vascular endothelial cells. J. Am. Soc. Nephrol. 11:2000;1819-1825
9. Heller R., Polack T., Grabner R., Till U. Nitric oxide inhibits proliferation of human endothelial cells via a mechanism independent of cGMP. Atherosclerosis. 144:1999;49-57
10. Jaffe E.A., Nachmann R.L., Becker C.G., Minick R. Culture of human endothelial cells derived from umbilical veins - identification by morphological and immunological criteria. J. Clin. Invest. 52:1973;2745-2756
11. Kalinowski L., Dobrucki L.W., Brovkovych V., Malinski T. Increased nitric oxide bioavailability in endothelial cells contributes to the pleiotropic effect of cerivastatin. Circulation. 105:2002;933-938
12. Kuzuya M., Satake S., Esaki T., Yamada K., Hayashi T., Naito M., Asai K., Iguchi A. Induction of angiogenesis by smooth muscle cell-derived factor: possible role in neovascularization in atherosclerotic plaque. J. Cell. Physiol. 164:1995;658-667
13. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation. 104:2001;365-372
14. Modifi R., Crotty T.B., McCarthy P., Sheehan S.J., Mehigan D., Keaveny T.V. Association between plaque instability, angiogenesis and symptomatic carotid occlusive disease. Br. J. Surg. 88:2001;941-944
15. Nilius B., Droogmans G. Ion channels and their functional role in vascular endothelium. Physiol. Rev. 81:2001;1415-1459
16. Rosenfeld M.E. Oxidized LDL affects multiple atherogenic cellular responses. Circulation. 83:1991;2137-2140
17. Ross R. Mechanisms of disease: atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340:1999;115-126
18. Sohn H.Y., Keller M., Gloe T., Morawietz H., Rueckschloss U., Pohl U. The small G-protein Rac mediates depolarization-induced superoxide formation in human endothelial cells. J. Biol. Chem. 275:2000;18745-18750
19. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. Beyond cholesterol: modification of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320:1989;915-924
20. Witztum J.L. Role of oxidized low density lipoprotein in atherogenesis. Br. Heart J. 69:1993;12-18
21. Wu R., Huang Y.H., Elinder L.S., Frostegard J. Lysophosphatidylcholine is involved in the antigenicity of oxidized LDL. Arterioscler. Thromb. Vasc. Biol. 18:1998;626-630
22. Yokoyama K., Ishibashi T., Ohkawara H., Kimura J., Matsuoka I., Sakamoto T., Nagata K., Sugimoto K., Sakurada S., Maruyama Y. HMG-CoA reductase inhibitors suppress intracellular calcium mobilization and membrane current induced by lysophosphatidylcholine in endothelial cells. Circulation. 105:2002;962-967